{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T04:09:19Z","timestamp":1747282159518,"version":"3.40.5"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,14]]},"DOI":"10.7759\/cureus.84085","type":"journal-article","created":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T10:13:26Z","timestamp":1747217606000},"source":"Crossref","is-referenced-by-count":0,"title":["Complement Dysregulation in Infancy: A Case of CD59 Deficiency With Neurological Sequelae"],"prefix":"10.7759","author":[{"given":"Fadi","family":"Busaleh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heeba Y","family":"Al Kalaf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nabil","family":"Almajhad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raneem","family":"Alhalal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jana M","family":"Alqahtani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra","family":"Almuslem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nouf","family":"AlQurashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manar  A","family":"Alhejji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zainab  I","family":"Albeladi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah B","family":"Alessa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1604483","article-title":"Neonatal-onset recurrent Guillain-Barr\u00e9 syndrome-like disease: clues for inherited CD59 deficiency","volume":"48","author":"Ardicli D","year":"2017","unstructured":"Ardicli D, Taskiran EZ, Kosukcu C, et al.. Neonatal-onset recurrent Guillain-Barr\u00e9 syndrome-like disease: clues for inherited CD59 deficiency. Neuropediatrics. 2017, 48:477-81. 10.1055\/s-0037-1604483","journal-title":"Neuropediatrics"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-065x.2000.917309.x","article-title":"Innate immune recognition: mechanisms and pathways","volume":"173","author":"Medzhitov R","year":"2000","unstructured":"Medzhitov R, Janeway C Jr. Innate immune recognition: mechanisms and pathways. Immunol Rev. 2000, 173:89-97. 10.1034\/j.1600-065x.2000.917309.x","journal-title":"Immunol Rev"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00262","article-title":"Complement system part I - molecular mechanisms of activation and regulation","volume":"6","author":"Merle NS","year":"2015","unstructured":"Merle NS, Church SE, Fremeaux-Bacchi V, Roumenina LT. Complement system part I - molecular mechanisms of activation and regulation. Front Immunol. 2015, 6:262. 10.3389\/fimmu.2015.00262","journal-title":"Front Immunol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2005.10.014","article-title":"Membrane complement regulatory proteins","volume":"118","author":"Kim DD","year":"2006","unstructured":"Kim DD, Song WC. Membrane complement regulatory proteins. Clin Immunol. 2006, 118:127-36. 10.1016\/j.clim.2005.10.014","journal-title":"Clin Immunol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-07-441857","article-title":"CD59 deficiency is associated with chronic hemolysis and childhood relapsing immune-mediated polyneuropathy","volume":"121","author":"Nevo Y","year":"2013","unstructured":"Nevo Y, Ben-Zeev B, Tabib A, et al.. CD59 deficiency is associated with chronic hemolysis and childhood relapsing immune-mediated polyneuropathy. Blood. 2013, 121:129-35. 10.1182\/blood-2012-07-441857","journal-title":"Blood"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1923","article-title":"Complement: a key system for immune surveillance and homeostasis","volume":"11","author":"Ricklin D","year":"2010","unstructured":"Ricklin D, Hajishengallis G, Yang K, Lambris JD. Complement: a key system for immune surveillance and homeostasis. Nat Immunol. 2010, 11:785-97. 10.1038\/ni.1923","journal-title":"Nat Immunol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2015.01.006","article-title":"Congenital CD59 deficiency","volume":"29","author":"H\u00f6chsmann B","year":"2015","unstructured":"H\u00f6chsmann B, Schrezenmeier H. Congenital CD59 deficiency. Hematol Oncol Clin North Am. 2015, 29:495-507. 10.1016\/j.hoc.2015.01.006","journal-title":"Hematol Oncol Clin North Am"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.2001.013381","article-title":"CD59 blocks not only the insertion of C9 into MAC but inhibits ion channel formation by homologous C5b-8 as well as C5b-9","volume":"539","author":"Farkas I","year":"2002","unstructured":"Farkas I, Baranyi L, Ishikawa Y, et al.. CD59 blocks not only the insertion of C9 into MAC but inhibits ion channel formation by homologous C5b-8 as well as C5b-9. J Physiol. 2002, 539:537-45. 10.1113\/jphysiol.2001.013381","journal-title":"J Physiol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830221029","article-title":"Paroxysmal nocturnal hemoglobinuria due to hereditary nucleotide deletion in the HRF20 (CD59) gene","volume":"22","author":"Motoyama N","year":"1992","unstructured":"Motoyama N, Okada N, Yamashina M, Okada H. Paroxysmal nocturnal hemoglobinuria due to hereditary nucleotide deletion in the HRF20 (CD59) gene. Eur J Immunol. 1992, 22:2669-73. 10.1002\/eji.1830221029","journal-title":"Eur J Immunol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199010253231707","article-title":"Inherited complete deficiency of 20-kilodalton homologous restriction factor (CD59) as a cause of paroxysmal nocturnal hemoglobinuria","volume":"323","author":"Yamashina M","year":"1990","unstructured":"Yamashina M, Ueda E, Kinoshita T, et al.. Inherited complete deficiency of 20-kilodalton homologous restriction factor (CD59) as a cause of paroxysmal nocturnal hemoglobinuria. N Engl J Med. 1990, 323:1184-9. 10.1056\/NEJM199010253231707","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpn.2015.07.001","article-title":"Devastating recurrent brain ischemic infarctions and retinal disease in pediatric patients with CD59 deficiency","volume":"19","author":"Ben-Zeev B","year":"2015","unstructured":"Ben-Zeev B, Tabib A, Nissenkorn A, et al.. Devastating recurrent brain ischemic infarctions and retinal disease in pediatric patients with CD59 deficiency. Eur J Paediatr Neurol. 2015, 19:688-93. 10.1016\/j.ejpn.2015.07.001","journal-title":"Eur J Paediatr Neurol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/pch\/10.7.397","article-title":"A schematic approach to hypotonia in infancy","volume":"10","author":"Leyenaar J","year":"2005","unstructured":"Leyenaar J, Camfield P, Camfield C. A schematic approach to hypotonia in infancy. Paediatr Child Health. 2005, 10:397-400. 10.1093\/pch\/10.7.397","journal-title":"Paediatr Child Health"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1055\/s-0035-1557381","article-title":"The hypotonic infant: Clinical approach","volume":"5","author":"Jan M","year":"2007","unstructured":"Jan M. The hypotonic infant: Clinical approach. Jr Ped Neur. 2007, 5:181-187. 10.1055\/s-0035-1557381","journal-title":"Jr Ped Neur"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.17712\/nsj.2023.2.20220119","article-title":"Inherited CD59 deficiency, where neurology and genetics intertwine","volume":"28","author":"Almutawea LM","year":"2023","unstructured":"Almutawea LM, Hajeri AA, Farid EM, et al.. Inherited CD59 deficiency, where neurology and genetics intertwine. Neurosciences (Riyadh). 2023, 28:130-5. 10.17712\/nsj.2023.2.20220119","journal-title":"Neurosciences (Riyadh)"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1208981","article-title":"Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome","volume":"368","author":"Legendre CM","year":"2013","unstructured":"Legendre CM, Licht C, Muus P, et al.. Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome. N Engl J Med. 2013, 368:2169-81. 10.1056\/NEJMoa1208981","journal-title":"N Engl J Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1038\/nbt1344","article-title":"Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria","volume":"25","author":"Rother RP","year":"2007","unstructured":"Rother RP, Rollins SA, Mojcik CF, et al.. Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria. Nat Biotechnol. 2007, 25:1256-64. 10.1038\/nbt1344","journal-title":"Nat Biotechnol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa031688","article-title":"Effect of eculizumab on hemolysis and transfusion requirements in patients with paroxysmal nocturnal hemoglobinuria","volume":"350","author":"Hillmen P","year":"2004","unstructured":"Hillmen P, Hall C, Marsh JC, et al.. Effect of eculizumab on hemolysis and transfusion requirements in patients with paroxysmal nocturnal hemoglobinuria. N Engl J Med. 2004, 350:552-9. 10.1056\/NEJMoa031688","journal-title":"N Engl J Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpn.2024.07.002","article-title":"Long term outcome in non-multiple sclerosis paediatric acquired demyelinating syndromes","volume":"52","author":"Wassmer E","year":"2024","unstructured":"Wassmer E, Billaud C, Absoud M, et al.. Long term outcome in non-multiple sclerosis paediatric acquired demyelinating syndromes. Eur J Paediatr Neurol. 2024, 52:52-8. 10.1016\/j.ejpn.2024.07.002","journal-title":"Eur J Paediatr Neurol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2019.07.004","article-title":"A retrospective cohort study of plasma exchange in central nervous system demyelinating events in children","volume":"35","author":"Manguinao M","year":"2019","unstructured":"Manguinao M, Krysko KM, Maddike S, et al.. A retrospective cohort study of plasma exchange in central nervous system demyelinating events in children. Mult Scler Relat Disord. 2019, 35:50-4. 10.1016\/j.msard.2019.07.004","journal-title":"Mult Scler Relat Disord"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/369153-complement-dysregulation-in-infancy-a-case-of-cd59-deficiency-with-neurological-sequelae","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T10:13:27Z","timestamp":1747217607000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/369153-complement-dysregulation-in-infancy-a-case-of-cd59-deficiency-with-neurological-sequelae"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,14]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.84085","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,14]]}}}